105 related articles for article (PubMed ID: 31009283)
1. Clinical Factors Associated With Cost in Head and Neck Cancer: Implications for a Bundled Payment Model.
Tom MC; Ross RB; Koyfman SA; Adelstein DJ; Lorenz RR; Burkey BB; Shah C; Suh JH; Bolwell BJ; Savage C; Platz S; Ward MC
J Oncol Pract; 2019 Jun; 15(6):e560-e567. PubMed ID: 31009283
[TBL] [Abstract][Full Text] [Related]
2. Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database.
Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
Clin Ther; 2018 Apr; 40(4):562-573. PubMed ID: 29530457
[TBL] [Abstract][Full Text] [Related]
3. Cost and Healthcare Utilization Among Non-Elderly Head and Neck Cancer Patients in the Military Health System, a Single-Payer Universal Health Care Model.
Ambrosio A; Jeffery DD; Hopkins L; Burke HB
Mil Med; 2019 May; 184(5-6):e400-e407. PubMed ID: 30295883
[TBL] [Abstract][Full Text] [Related]
4. An Analysis of 1-Year Charges for Head and Neck Cancer: Targets for Value-Based Interventions.
Pang J; Crawford K; Faraji F; Ramsey C; Kemp A; Califano JA
Otolaryngol Head Neck Surg; 2020 Sep; 163(3):546-553. PubMed ID: 32450778
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of cisplatin-based chemoradiation to treat patients with unresectable, nonmetastatic head and neck cancer in Brazil.
Brentani A; de Castro G; Federico MH
Head Neck; 2011 Aug; 33(8):1199-205. PubMed ID: 21755563
[TBL] [Abstract][Full Text] [Related]
6. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
[TBL] [Abstract][Full Text] [Related]
7. Predicting Costs Exceeding Bundled Payment Targets for Total Joint Arthroplasty.
Ryan SP; Goltz DE; Howell CB; Jiranek WA; Attarian DE; Bolognesi MP; Seyler TM
J Arthroplasty; 2019 Mar; 34(3):412-417. PubMed ID: 30518476
[TBL] [Abstract][Full Text] [Related]
8. Economic Burden of Head and Neck Cancer Treatment in North India.
Chauhan AS; Prinja S; Ghoshal S; Verma R
Asian Pac J Cancer Prev; 2019 Feb; 20(2):403-409. PubMed ID: 30803199
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of head and neck cancer: a systematic literature review.
Wissinger E; Griebsch I; Lungershausen J; Foster T; Pashos CL
Pharmacoeconomics; 2014 Sep; 32(9):865-82. PubMed ID: 24842794
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care center.
Nonzee NJ; Dandade NA; Patel U; Markossian T; Agulnik M; Argiris A; Patel JD; Kern RC; Munshi HG; Calhoun EA; Bennett CL
Cancer; 2008 Sep; 113(6):1446-52. PubMed ID: 18683883
[TBL] [Abstract][Full Text] [Related]
11. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
13. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
[TBL] [Abstract][Full Text] [Related]
14. Development and Feasibility of Bundled Payments for the Multidisciplinary Treatment of Head and Neck Cancer: A Pilot Program.
Spinks T; Guzman A; Beadle BM; Lee S; Jones D; Walters R; Incalcaterra J; Hanna E; Hessel A; Weber R; Denney S; Newcomer L; Feeley TW
J Oncol Pract; 2018 Feb; 14(2):e103-e112. PubMed ID: 29272202
[TBL] [Abstract][Full Text] [Related]
15. Preoperative combined chemotherapy and radiation therapy plus radical surgery in advanced head and neck cancer. Five-year results with impressive complete response rates and high survival.
Slotman GJ; Doolittle CH; Glicksman AS
Cancer; 1992 Jun; 69(11):2736-43. PubMed ID: 1571903
[TBL] [Abstract][Full Text] [Related]
16. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
17. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
18. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome for head and neck squamous cell carcinoma in a developing country: University Malaya Medical Centre, Malaysia from 2003-2010.
Wong YF; Yusof MM; Wan Ishak WZ; Alip A; Phua VC
Asian Pac J Cancer Prev; 2015; 16(7):2903-8. PubMed ID: 25854381
[TBL] [Abstract][Full Text] [Related]
20. Out-of-pocket costs associated with head and neck cancer treatment.
Khan MN; Hueniken K; Manojlovic-Kolarski M; Eng L; Mirshams M; Khan K; Simpson C; Au M; Liu G; Xu W; Longo CJ; Goldstein DP; Ringash J; Martino R; Hansen AR; de Almeida JR
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1528. PubMed ID: 34428351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
